Company page

Brii Biosciences Limited

Brii Biosciences Limited, trading under the ticker 2137 on the Hong Kong Stock Exchange, is a biotechnology company focused on developing innovative therapies for infectious diseases and other serious health conditions. The company has a market capitalization of approximately HKD 105.93 million. Brii Biosciences is dedicated to advancing its research and product pipeline to address unmet medical needs.